Assignee
REXAHN PHARMACEUTICALS INC
US·12 granted patents·5 pending applications·12 citations·filing 2005–2020
Top patents by PatentIndex Score
17 records- 0189US9150520B2Process for the preparation of 4-amino-1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-oneREXAHN PHARMACEUTICALS INC·Filed 2014·Granted Oct 6, 2015·8 cites·29 claims
- 0279US9533958B2Process or the preparation of 4-amino 1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-Enyl)-1H-pyrimidin-2-oneREXAHN PHARMACEUTICALS INC·Filed 2015·Granted Jan 3, 2017·2 cites·20 claims
- 0373US8034829B25, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives and therapeutic use thereofREXAHN PHARMACEUTICALS INC·Filed 2007·Granted Oct 11, 2011·2 cites·18 claims
- 0463US2015071872A1Polymeric systems for the delivery of anticancer drugsREXAHN PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0559US2020231553A1Quinoxalinyl-piperazinamide methods of useREXAHN PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0659US2009270358A1Pharmaceutical formulation of clavulanic acidREXAHN PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0758US9920016B2Process for the preparation of 4-amino 1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-oneREXAHN PHARMACEUTICALS INC·Filed 2016·Granted Mar 20, 2018·0 cites·16 claims
- 0856US10570101B2Quinoxalinyl-piperazinamide methods of useREXAHN PHARMACEUTICALS INC·Filed 2018·Granted Feb 25, 2020·0 cites·12 claims
- 0956US9744167B2Nanoparticulate compositions and formulations of piperazine compoundsREXAHN PHARMACEUTICALS INC·Filed 2014·Granted Aug 29, 2017·0 cites·19 claims
- 1053US9713615B2Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone compoundsREXAHN PHARMACEUTICALS INC·Filed 2015·Granted Jul 25, 2017·0 cites·21 claims
- 1152US10278971B2Fluorocyclopentenylcytosine methods of useREXAHN PHARMACEUTICALS INC·Filed 2017·Granted May 7, 2019·0 cites·17 claims
- 1252US10052321B2Nanoparticulate compositions and formulations of piperazine compoundsREXAHN PHARMACEUTICALS INC·Filed 2017·Granted Aug 21, 2018·0 cites·23 claims
- 1351US9969698B2Quinoxalinyl-piperazinamide methods of useREXAHN PHARMACEUTICALS INC·Filed 2016·Granted May 15, 2018·0 cites·13 claims
- 1451US2019275042A1Fluorocyclopentenylcytosine methods of useREXAHN PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1550US9782410B2Fluorocyclopentenylcytosine methods of useREXAHN PHARMACEUTICALS INC·Filed 2016·Granted Oct 10, 2017·0 cites·21 claims
- 1650US7388014B2Quinazoline derivatives and therapeutic use thereofREXAHN PHARMACEUTICALS INC·Filed 2005·Granted Jun 17, 2008·0 cites·19 claims
- 1734US2010255099A1Clavulanate formulation for neuroprotection and treatment of neurodegenerative disordersREXAHN PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →